bibliographic resource 1736335 [br/1736335]
https://w3id.org/oc/corpus/br/1736335

is a

• document
• article

title

• Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

publication date

• 2013-01-01

contributor

• https://w3id.org/oc/corpus/ar/6105487
• https://w3id.org/oc/corpus/ar/6105488
• https://w3id.org/oc/corpus/ar/6105489
• https://w3id.org/oc/corpus/ar/6105490
• https://w3id.org/oc/corpus/ar/6105491
• https://w3id.org/oc/corpus/ar/6105492
• https://w3id.org/oc/corpus/ar/6105493
• https://w3id.org/oc/corpus/ar/6105494
• https://w3id.org/oc/corpus/ar/6105495
• https://w3id.org/oc/corpus/ar/6105496
• https://w3id.org/oc/corpus/ar/6105497
• https://w3id.org/oc/corpus/ar/6105498
• https://w3id.org/oc/corpus/ar/6105499
• https://w3id.org/oc/corpus/ar/6105500
• https://w3id.org/oc/corpus/ar/6105501
• https://w3id.org/oc/corpus/ar/6105502

format

• https://w3id.org/oc/corpus/re/872913

identifier

• https://w3id.org/oc/corpus/id/3139682
• https://w3id.org/oc/corpus/id/3139683
• https://w3id.org/oc/corpus/id/3139684

part of

• https://w3id.org/oc/corpus/br/324021